Patents Assigned to OM Pharma SA
  • Patent number: 11801271
    Abstract: The present invention relates to novel stable bacterial extract preparations having substantial increased stability over time, novel methods of preparation thereof, pharmaceutical formulations based on these novel stabilized bacterial extracts, as well as novel routes of administration and delivery devices for treating and/or preventing acute and chronic immunological disorders resulting from infections and/or inflammation and/or neoplasms and/or dysbiosis.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: October 31, 2023
    Assignee: OM PHARMA SA
    Inventors: Jacques Bauer, Christian Pasquali
  • Patent number: 9463209
    Abstract: The present invention relates to an extract from bacterial strains, such as Staphylococcus, Moraxella, Klebsiella, Streptococcus, and Haemophilus. The extract is useful as a treatment for indications such as respiratory disorders, compositions comprising the extract, and processes of making the extract from media that do not pose a risk of prion diseases.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: October 11, 2016
    Assignee: OM PHARMA SA
    Inventors: Jacques Alain Bauer, Marco Salvagni, Jean-Pierre Leon Vigroux, Laetitia Chalvet, Carlo Chiavaroli
  • Publication number: 20140205693
    Abstract: The present invention relates to an extract from bacterial strains, such as Staphylococcus, Moraxella, Klebsiella, Streptococcus, and Haemophilus. The extract is useful as a treatment for indications such as respiratory disorders, compositions comprising the extract, and processes of making the extract from media that do not pose a risk of prion diseases.
    Type: Application
    Filed: March 20, 2014
    Publication date: July 24, 2014
    Applicant: OM PHARMA SA
    Inventors: Jacques Alain BAUER, Marco SALVAGNI, Jean-Pierre Leon VIGROUX, Laetitia CHALVET, Carlo CHIAVAROLI
  • Patent number: 8697154
    Abstract: The present invention relates to an extract from bacterial strains, such as Staphylococcus, Moraxella, Klebsiella, Streptococcus, and Haemophilus. The extract is useful as a treatment for indications such as respiratory disorders, compositions comprising the extract, and processes of making the extract from media that do not pose a risk of prion diseases.
    Type: Grant
    Filed: March 5, 2008
    Date of Patent: April 15, 2014
    Assignee: OM Pharma SA
    Inventors: Jacques Alain Bauer, Marco Salvagni, Jean-Pierre Leon Vigroox, Laetitia Chalvet, Carlo Chiavaroli